Health Care

Healthcare Stock Update: CVS Health Corporation (NYSE:CVS)

0

CVS Health Corporation (NYSE:CVS) closed its last session at $89.44 with the change of -1.64%. The market capitalization of the company is $95.36B with an average Volume of 4.87 million shares. The stock currently has its 52-Week High range of $106.67 and 52-week low range of $86.50. The Price to Book (P/B) ratio stands at 2.79. The stock traded total quantity of 7.94 million shares.

Currently CVS Health Corporation (CVS) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “18″ Analysts”. “0” rated “Sell” for the company. “4” said the company as a “Hold”. Overweight rating was given by “3” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $112.76 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $123.00 however minimum price target advised by analysts is $104.00. The Median price target for the stock is measured at $112.00.

Presently, Analysts decided consensus EPS estimate of $1.57 for present quarter and one month ago projected EPS estimate was at $1.57. If we take a look at back 3 month ago, consensus EPS estimate was $1.55.

A current consensus EPS estimate for next quarter is at $1.79 and 3 month ago EPS forecast was $1.79. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.79.

For current fiscal year, most recent EPS estimate is set at $5.86 based on Analyst consensus and three month ago consensus EPS opinions was at $5.82. During period one month ago, consensus EPS forecast was decided at $5.86.

A current consensus EPS projection for next fiscal year is observed at $6.57 and one month ago consensus EPS forecast was at $6.57. Take a look at back three month ago, consensus EPS estimate opinions was decided at $6.57 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 17 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 3. 5 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 20 said a “Buy Rating” and 3 announced “Overweight Rating”. 4 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter